Using conditional genetic mouse models of BCC, we demonstrate that IL6 signaling is required for the formation of HH/GLI‐driven BCC in vivo by synergistically promoting the proliferative effect of oncogenic HH/GLI signaling. This evidence concerns the gene IL6 and skin basal cell carcinoma.